Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Insulin Resistant Patients With Mood Disorders
NCT01559857Phase 4Completed
- Sponsor
- Stanford University
- Start
- Nov 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Stanford University. Started Nov 2011; status: completed.
02
Drugs
pioglitazone
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01559857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01559857.